Methods and compositions relating to CD39-like polypeptides and nucleic acids
View Patent ↗The present invention provides polynucleotides and proteins encoded by such polynucleotides, along with therapeutic, diagnostic and research utilities for these polynucleotides and proteins. In particular, the polypeptides and polynucleotides of the invention comprise amino acid and nucleic acid sequences of novel CD39-like gene and gene products.
1. An isolated antibody or antigen binding fragment thereof which specifically binds to a CD39L2 polypeptide comprising the amino acid sequence of SEQ ID NO: 2.
2. The antibody or antigen binding fragment thereof of claim 1 , wherein the antibody is a monoclonal antibody.
3. The antibody or antigen binding fragment thereof of claim 1 , wherein the antigen binding fragment is an antigen binding fragment of a monoclonal antibody.
4. A hybridoma which produces the monoclonal antibody of claim 2 .
5. The antibody or antigen binding fragment thereof of claim 1 , wherein the antibody is a polyclonal antibody.
6. The antibody or antigen binding fragment thereof of claim 1 , wherein the antigen binding fragment is an antigen binding fragment of a polyclonal antibody.
7. A labeled antibody or antigen binding fragment thereof, wherein the antibody or antigen binding fragment thereof of claim 1 is labeled with a detectable label.
8. The labeled antibody or antigen binding fragment thereof of claim 7 , wherein the detectable label is a radioisotope, affinity label, enzymatic label, fluorescent label or paramagnetic moiety.
9. A kit comprising (a) the antibody or antigen binding fragment of claim 1 and (b) a polypeptide comprising the amino acid sequence of SEQ ID NO: 2 or an immunologically reactive fragment of said polypeptide.
10. A kit comprising (a) the antibody or antigen binding fragment thereof of claim 1 and (b) a wash reagent or a reagent capable of detecting the presence of the bound antibody.